Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs

被引：311

作者：

Bach, Peter B. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 06期

关键词：

CHEMOTHERAPY; CARE; PRESCRIPTION; PAYMENT; REIMBURSEMENT; INTERFERON; HEALTH; COSTS; PRICE;

D O I：

10.1056/NEJMhpr0807774

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：626 / 633

页数：8

相关论文

共 34 条

[1] The first months of the prescription-drug benefit - A CMS update
Bach, PB
McClellan, MB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22) : 2312 - 2314
[2] A prescription for a modern Medicare program
Bach, PB
McClellan, MB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26) : 2733 - 2735
[3] Using practice guidelines to assess cancer care quality
Bach, PB
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9041 - 9043
[4] Costs of cancer care: A view from the centers for Medicare & Medicaid services
Bach, Peter B.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (02) : 187 - 190
[5] Berenson Alex, 2006, N Y Times Web, pC2
[6] Access to cancer drugs in Medicare Part D: Formulary placement and beneficiary cost sharing in 2006
Bowman, Jennifer
Rousseau, Amy
Silk, David
Harrison, Catherine
[J]. HEALTH AFFAIRS, 2006, 25 (05) : 1240 - 1248
[7] Timeline - Chemotherapy and the war on cancer
Chabner, BA
Roberts, TG
[J]. NATURE REVIEWS CANCER, 2005, 5 (01) : 65 - 72
[8] *CTR MED MED SERV, 2007, PROP DEC MEM ER STIM
[9] Insurers and 'Targeted Biologics' for cancer: A conversation with Lee N. Newcomer
Culliton, Barbara J.
Newcomer, Lee
[J]. HEALTH AFFAIRS, 2008, 27 (01) : W41 - W51
[10] *DEP HHS, 2004, MED REIMB LUPR

← 1 2 3 4 →